Autophagy, Metabolism, and Cancer.

PubWeight™: 0.95‹?› | Rank: Top 15%

🔗 View Article (PMID 26567363)

Published in Clin Cancer Res on November 15, 2015

Authors

Eileen White1, Janice M Mehnert2, Chang S Chan2

Author Affiliations

1: Rutgers Cancer Institute of New Jersey (CINJ), New Brunswick, New Jersey. Department of Molecular Biology and Biochemistry, Rutgers University, Piscataway, New Jersey. epwhite@cinj.rutgers.edu.
2: Rutgers Cancer Institute of New Jersey (CINJ), New Brunswick, New Jersey. Department of Medicine, Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, New Jersey.

Articles citing this

Mitochondria and Cancer. Mol Cell (2016) 1.11

Recent insights into the function of autophagy in cancer. Genes Dev (2016) 0.86

Autophagy provides metabolic substrates to maintain energy charge and nucleotide pools in Ras-driven lung cancer cells. Genes Dev (2016) 0.84

BCL-2 Antagonism to Target the Intrinsic Mitochondrial Pathway of Apoptosis. Clin Cancer Res (2015) 0.82

Starving cancer from the outside and inside: separate and combined effects of calorie restriction and autophagy inhibition on Ras-driven tumors. Cancer Metab (2016) 0.78

Inflammation as a driver and vulnerability of KRAS mediated oncogenesis. Semin Cell Dev Biol (2016) 0.76

Metabolic Imaging to Assess Treatment Response to Cytotoxic and Cytostatic Agents. Front Oncol (2016) 0.76

"Get the Balance Right": Pathological Significance of Autophagy Perturbation in Neuromuscular Disorders. J Neuromuscul Dis (2016) 0.76

Changing perspective on oncometabolites: from metabolic signature of cancer to tumorigenic and immunosuppressive agents. Oncotarget (2016) 0.76

Inhibition of the Autophagy Pathway Synergistically Potentiates the Cytotoxic Activity of Givinostat (ITF2357) on Human Glioblastoma Cancer Stem Cells. Front Mol Neurosci (2016) 0.76

Endoplasmic Reticulum-Mitochondrial Ca(2+) Fluxes Underlying Cancer Cell Survival. Front Oncol (2017) 0.75

Phospholipase D1-regulated autophagy supplies free fatty acids to counter nutrient stress in cancer cells. Cell Death Dis (2016) 0.75

Transcriptional Regulation of Core Autophagy and Lysosomal Genes by the Androgen Receptor Promotes Prostate Cancer Progression. Autophagy (2016) 0.75

Dysregulation of Autophagy Contributes to Anal Carcinogenesis. PLoS One (2016) 0.75

Halofuginone dually regulates autophagic flux through nutrient-sensing pathways in colorectal cancer. Cell Death Dis (2017) 0.75

Obesity and Cancer Metabolism: A Perspective on Interacting Tumor-Intrinsic and Extrinsic Factors. Front Oncol (2017) 0.75

Cancer: Linking Powerhouses to Suicidal Bags. Front Oncol (2017) 0.75

Suppression of p53 potentiates chemosensitivity in nutrient-deprived cholangiocarcinoma cells via inhibition of autophagy. Oncol Lett (2017) 0.75

Lysosomal Biology in Cancer. Methods Mol Biol (2017) 0.75

Protective effects of heme oxygenase-1-transduced bone marrow-derived mesenchymal stem cells on reduced‑size liver transplantation: Role of autophagy regulated by the ERK/mTOR signaling pathway. Int J Mol Med (2017) 0.75

Articles cited by this

Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature (1999) 23.62

The role of autophagy during the early neonatal starvation period. Nature (2004) 22.40

Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. J Cell Biol (2005) 18.60

In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Mol Biol Cell (2003) 17.55

Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest (2003) 16.67

Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci U S A (2003) 15.59

Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell (2007) 14.63

Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell (2006) 11.79

Autophagy: renovation of cells and tissues. Cell (2011) 11.59

Autophagy suppresses tumorigenesis through elimination of p62. Cell (2009) 9.95

Autophagy in human health and disease. N Engl J Med (2013) 8.71

The role of Atg proteins in autophagosome formation. Annu Rev Cell Dev Biol (2011) 8.18

Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proc Natl Acad Sci U S A (2010) 8.12

Autophagy and metabolism. Science (2010) 8.10

Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev (2011) 7.43

Autophagy suppresses tumor progression by limiting chromosomal instability. Genes Dev (2007) 7.41

Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis. Genes Dev (2007) 6.35

Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21. Genomics (1999) 6.23

Pancreatic cancers require autophagy for tumor growth. Genes Dev (2011) 6.17

Deconvoluting the context-dependent role for autophagy in cancer. Nat Rev Cancer (2012) 6.14

Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells. Nature (2013) 4.71

Autophagy-deficient mice develop multiple liver tumors. Genes Dev (2011) 4.64

The signaling adaptor p62 is an important NF-kappaB mediator in tumorigenesis. Cancer Cell (2008) 4.48

p53 status determines the role of autophagy in pancreatic tumour development. Nature (2013) 4.31

Autophagy in infection, inflammation and immunity. Nat Rev Immunol (2013) 4.16

Autophagy facilitates glycolysis during Ras-mediated oncogenic transformation. Mol Biol Cell (2010) 3.63

Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function. Nature (2014) 3.34

Mitochondrial genome acquisition restores respiratory function and tumorigenic potential of cancer cells without mitochondrial DNA. Cell Metab (2015) 3.06

Suppression of autophagy by FIP200 deletion inhibits mammary tumorigenesis. Genes Dev (2011) 3.05

Autophagy suppresses progression of K-ras-induced lung tumors to oncocytomas and maintains lipid homeostasis. Genes Dev (2013) 2.90

Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer. Nat Rev Clin Oncol (2013) 2.64

Concern Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-q27. Proc Natl Acad Sci U S A (2003) 2.52

Autophagy is required for glucose homeostasis and lung tumor maintenance. Cancer Discov (2014) 2.44

Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides. Nature (2014) 2.27

Defective regulation of autophagy upon leucine deprivation reveals a targetable liability of human melanoma cells in vitro and in vivo. Cancer Cell (2011) 2.24

The role for autophagy in cancer. J Clin Invest (2015) 2.11

Autophagy-mediated tumor promotion. Cell (2013) 2.08

Pan-cancer genetic analysis identifies PARK2 as a master regulator of G1/S cyclins. Nat Genet (2014) 2.01

Transcriptional control of autophagy-lysosome function drives pancreatic cancer metabolism. Nature (2015) 2.00

Combined MTOR and autophagy inhibition: phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma. Autophagy (2014) 1.98

Autophagy is critical for pancreatic tumor growth and progression in tumors with p53 alterations. Cancer Discov (2014) 1.97

A dual role for autophagy in a murine model of lung cancer. Nat Commun (2014) 1.97

p62: a versatile multitasker takes on cancer. Trends Biochem Sci (2012) 1.93

Heterogeneity of tumor-induced gene expression changes in the human metabolic network. Nat Biotechnol (2013) 1.91

Small Molecule Inhibition of the Autophagy Kinase ULK1 and Identification of ULK1 Substrates. Mol Cell (2015) 1.86

A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme. Autophagy (2014) 1.85

Combined autophagy and proteasome inhibition: a phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed/refractory myeloma. Autophagy (2014) 1.84

Measurements of tumor cell autophagy predict invasiveness, resistance to chemotherapy, and survival in melanoma. Clin Cancer Res (2011) 1.84

Autophagy inhibitor Lys05 has single-agent antitumor activity and reproduces the phenotype of a genetic autophagy deficiency. Proc Natl Acad Sci U S A (2012) 1.82

Targeting ER stress-induced autophagy overcomes BRAF inhibitor resistance in melanoma. J Clin Invest (2014) 1.81

Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma. Autophagy (2014) 1.77

Punctate LC3B expression is a common feature of solid tumors and associated with proliferation, metastasis, and poor outcome. Clin Cancer Res (2011) 1.69

Combined autophagy and HDAC inhibition: a phase I safety, tolerability, pharmacokinetic, and pharmacodynamic analysis of hydroxychloroquine in combination with the HDAC inhibitor vorinostat in patients with advanced solid tumors. Autophagy (2014) 1.67

Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy. Nature (2014) 1.65

Potential applications for biguanides in oncology. J Clin Invest (2013) 1.63

Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo. Nat Cell Biol (2014) 1.46

Exploiting the bad eating habits of Ras-driven cancers. Genes Dev (2013) 1.45

Learning from oncocytic tumors: Why choose inefficient mitochondria? Biochim Biophys Acta (2010) 1.40

Coordinate autophagy and mTOR pathway inhibition enhances cell death in melanoma. PLoS One (2013) 1.32

Autophagy opposes p53-mediated tumor barrier to facilitate tumorigenesis in a model of PALB2-associated hereditary breast cancer. Cancer Discov (2013) 1.32

Autophagy-dependent production of secreted factors facilitates oncogenic RAS-driven invasion. Cancer Discov (2014) 1.28

A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy. Nat Chem Biol (2014) 1.27

Emerging strategies to effectively target autophagy in cancer. Oncogene (2015) 1.26

Defects in mitochondrial metabolism and cancer. Cancer Metab (2014) 1.24

SHMT2 drives glioma cell survival in ischaemia but imposes a dependence on glycine clearance. Nature (2015) 1.22

SQSTM1 is a pathogenic target of 5q copy number gains in kidney cancer. Cancer Cell (2013) 1.15

Autophagy inhibition improves chemosensitivity in BRAF(V600E) brain tumors. Cancer Discov (2014) 1.14

Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. Autophagy (2014) 1.14

Mutational landscape of the essential autophagy gene BECN1 in human cancers. Mol Cancer Res (2014) 1.13

Decreased BECN1 mRNA Expression in Human Breast Cancer is Associated with Estrogen Receptor-Negative Subtypes and Poor Prognosis. EBioMedicine (2015) 1.04

Atg7 Overcomes Senescence and Promotes Growth of BrafV600E-Driven Melanoma. Cancer Discov (2015) 1.02

Autophagy promotes BrafV600E-driven lung tumorigenesis by preserving mitochondrial metabolism. Autophagy (2013) 1.02

p62/SQSTM1 synergizes with autophagy for tumor growth in vivo. Genes Dev (2014) 1.01

Autophagy is required for mitochondrial function, lipid metabolism, growth, and fate of KRAS(G12D)-driven lung tumors. Autophagy (2013) 0.98

Functional role of autophagy-mediated proteome remodeling in cell survival signaling and innate immunity. Mol Cell (2014) 0.96

Targeting mitochondrial metabolism by inhibiting autophagy in BRAF-driven cancers. Cancer Discov (2014) 0.94

Promises and Challenges of Smac Mimetics as Cancer Therapeutics. Clin Cancer Res (2015) 0.93

Pharmacological inhibition of ULK1 kinase blocks mammalian target of rapamycin (mTOR)-dependent autophagy. J Biol Chem (2015) 0.92

Analysis of a lung defect in autophagy-deficient mouse strains. Autophagy (2013) 0.92

Discovery of (2S)-8-[(3R)-3-methylmorpholin-4-yl]-1-(3-methyl-2-oxobutyl)-2-(trifluoromethyl)-3,4-dihydro-2H-pyrimido[1,2-a]pyrimidin-6-one: a novel potent and selective inhibitor of Vps34 for the treatment of solid tumors. J Med Chem (2014) 0.91

Beclin 1 regulates growth factor receptor signaling in breast cancer. Oncogene (2015) 0.90

Beyond indigestion: emerging roles for lysosome-based signaling in human disease. Curr Opin Cell Biol (2015) 0.89

Inhibition of autophagy enhances the effects of the AKT inhibitor MK-2206 when combined with paclitaxel and carboplatin in BRAF wild-type melanoma. Pigment Cell Melanoma Res (2014) 0.88

Context-dependent role of ATG4B as target for autophagy inhibition in prostate cancer therapy. Biochem Biophys Res Commun (2013) 0.87

Identification of a lung cancer cell line deficient in atg7-dependent autophagy. Autophagy (2015) 0.87

Mouse models address key concerns regarding autophagy inhibition in cancer therapy. Cancer Discov (2014) 0.82

BCL-2 Antagonism to Target the Intrinsic Mitochondrial Pathway of Apoptosis. Clin Cancer Res (2015) 0.82